Inclusion Criteria:  Stable angina patients referred for elective percutaneous coronary intervention (PCI), or non-ST-elevation myocardial infarction (NSTEMI) and unstable angina (UA) patients (undergoing PCI at least 12 hours after diagnosis for NSTEMI/UA, consistently hemodynamically stable, with thrombolysis in myocardial infarction (TIMI) Flow Grade (TFG) 3 on the diagnostic angiography) Target lesions for PCI must appear suitable for stenting as confirmed on the diagnostic angiography and must satisfy the study criteria regarding lesion size and vessel diameter/type Females must not be of childbearing potential Males with pregnant or non-pregnant female partners of childbearing potential must agree to using a condom during treatment and for 90 days following treatment  Exclusion Criteria:  Planned or anticipated use of rotational atherectomy/ablation or shockwave therapies during the PCI procedure Any history of stroke, head injury, seizure, intracranial bleeding, or intracranial aneurysm Transient ischemic attack within the 6 months prior to Screening History of major trauma, major surgery, and/or clinically significant hemorrhage within the last 6 months of Screening NSTEMI/UA with cardiac troponin (cTn) levels that are increasing (not stable or dropping) as shown by the 2 most recent measures after diagnosis of NSTEMI/UA and prior to randomization Any ST-elevation myocardial infarction (STEMI) within 10 days of Screening or STEMI within the target vessel territory within the last 6 months of Screening